Dr. Mark Brown, MD

Anesthesiology Sugarland, TX Male
NPI: 1558332221
Total Payments
$166.59
2022 Payments
$21.00
Companies
5
Transactions
12
Medicare Patients
448
Medicare Billing
$204,312

Payment Breakdown by Category

Food & Beverage$145.59 (87.4%)
Education$21.00 (12.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $145.59 11 87.4%
Education $21.00 1 12.6%

Top Paying Companies

Company Total Records Latest Year
Collegium Pharmaceutical, Inc. $73.90 5 $0 (2017)
Purdue Pharma L.P. $31.31 3 $0 (2017)
Valeant Pharmaceuticals North America LLC $23.50 2 $0 (2017)
Hikma Pharmaceuticals USA $21.00 1 $0 (2022)
Daiichi Sankyo Inc. $16.88 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2022 $21.00 1 Hikma Pharmaceuticals USA ($21.00)
2017 $145.59 11 Collegium Pharmaceutical, Inc. ($73.90)

All Payment Transactions

12 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
04/11/2022 Hikma Pharmaceuticals USA Kloxxado (Drug) Education In-kind items and services $21.00 General
Category: Pulmonary/Respiratory Diseases
12/07/2017 Collegium Pharmaceutical, Inc. Xtampza ER (Drug) Food and Beverage Cash or cash equivalent $11.17 General
Category: Opioid Analgesic
11/16/2017 Purdue Pharma L.P. SYMPROIC (Drug) Food and Beverage Cash or cash equivalent $10.47 General
Category: CONSTIPATION
10/17/2017 Collegium Pharmaceutical, Inc. Xtampza ER (Drug) Food and Beverage Cash or cash equivalent $15.29 General
Category: Opioid Analgesic
09/26/2017 Daiichi Sankyo Inc. Movantik (Drug) Food and Beverage In-kind items and services $16.88 General
Category: Opioid Induced Constipation
09/12/2017 Collegium Pharmaceutical, Inc. XTAMPZA ER (Drug) Food and Beverage Cash or cash equivalent $14.00 General
Category: opioid analgesic
06/20/2017 Valeant Pharmaceuticals North America LLC RELISTOR ORAL (Drug) Food and Beverage In-kind items and services $12.33 General
Category: GASTROENTEROLOGY
06/01/2017 Collegium Pharmaceutical, Inc. Xtampza ER (Drug) Food and Beverage Cash or cash equivalent $15.68 General
Category: Opioid Analgesic
05/18/2017 Purdue Pharma L.P. OXYCONTIN (Drug), HYSINGLA ER, BUTRANS Food and Beverage Cash or cash equivalent $10.44 General
Category: PAIN MANAGEMENT
04/13/2017 Collegium Pharmaceutical, Inc. Xtampza ER (Drug) Food and Beverage Cash or cash equivalent $17.76 General
Category: Opioid Analgesic
04/04/2017 Valeant Pharmaceuticals North America LLC RELISTOR ORAL (Drug) Food and Beverage In-kind items and services $11.17 General
Category: GASTROENTEROLOGY
02/28/2017 Purdue Pharma L.P. BUTRANS (Drug), OXYCONTIN, HYSINGLA ER Food and Beverage Cash or cash equivalent $10.40 General
Category: PAIN MANAGEMENT

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 76 290 $92,682 $23,657
2022 3 105 677 $219,362 $61,703
2021 2 105 714 $237,184 $67,325
2020 3 162 706 $219,476 $51,628
Total Patients
448
Total Services
2,387
Medicare Billing
$204,312
Procedure Codes
10

All Medicare Procedures & Services

10 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 65 267 $87,576 $22,430 25.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 11 23 $5,106 $1,227 24.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 79 617 $202,376 $56,939 28.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 13 47 $10,434 $3,088 29.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 13 13 $6,552 $1,676 25.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 88 697 $228,616 $65,103 28.5%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 17 17 $8,568 $2,222 25.9%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 93 560 $183,680 $42,753 23.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 57 134 $29,748 $7,665 25.8%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 12 12 $6,048 $1,210 20.0%

About Dr. Mark Brown, MD

Dr. Mark Brown, MD is a Anesthesiology healthcare provider based in Sugarland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558332221.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Brown, MD has received a total of $166.59 in payments from pharmaceutical and medical device companies, with $21.00 received in 2022. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($145.59).

As a Medicare-enrolled provider, Brown has provided services to 448 Medicare beneficiaries, totaling 2,387 services with total Medicare billing of $204,312. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.

Practice Information

  • Specialty Anesthesiology
  • Other Specialties Pain Medicine
  • Location Sugarland, TX
  • Active Since 01/30/2006
  • Last Updated 04/09/2019
  • Taxonomy Code 207L00000X
  • Entity Type Individual
  • NPI Number 1558332221

Products in Payments

  • Xtampza ER (Drug) $59.90
  • RELISTOR ORAL (Drug) $23.50
  • Kloxxado (Drug) $21.00
  • Movantik (Drug) $16.88
  • XTAMPZA ER (Drug) $14.00
  • SYMPROIC (Drug) $10.47
  • OXYCONTIN (Drug) $10.44
  • BUTRANS (Drug) $10.40

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.